<p>Arbejdsmarkedets Tillaegspension 在最近向證券交易委員會的披露中表示，在第四季度購買了 Medtronic PLC（紐約證券交易所代碼：MDT - 免費報告）的新股份。該基金購買了 233,477 股這家醫療技術公司的股票，價值約為 22,428,000 美元。</p>
<ul>
<li>分析師喜愛 DexCom 的 3 個理由</li>
</ul>
<p>其他一些大型投資者最近也買賣了該公司的股票。Brighton Jones LLC 在第四季度將其在 Medtronic 的持股比例提高了 1,368.0%。Brighton Jones LLC 現在擁有 39,989 股這家醫療技術公司的股票，價值 3,194,000 美元，此前在該期間內又購買了 37,265 股。Sivia Capital Partners LLC 在第二季度將其在 Medtronic 的持股比例提高了 9.6%。Sivia Capital Partners LLC 現在擁有 4,356 股這家醫療技術公司的股票，價值 380,000 美元，此前在上個季度又購買了 381 股。Jump Financial LLC 在第二季度購買了 Medtronic 的新股份，價值約為 299,000 美元。Main Street Financial Solutions LLC 在第二季度將其在 Medtronic 的持股比例提高了 28.9%。Main Street Financial Solutions LLC 現在擁有 14,356 股這家醫療技術公司的股票，價值 1,251,000 美元，此前在上個季度又購買了 3,218 股。最後，HUB Investment Partners LLC 在第二季度將其在 Medtronic 的持股比例提高了 21.3%。HUB Investment Partners LLC 現在擁有 19,226 股這家醫療技術公司的股票，價值 1,676,000 美元，此前在該期間內又購買了 3,376 股。82.06% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>Medtronic 股價表現</h2>
<p>MDT 股票在週五開盤價為 76.12 美元。該公司的市值為 977.3 億美元，市盈率為 21.20，市盈增長比率為 1.83，貝塔值為 0.62。Medtronic PLC 的 12 個月低點為 74.40 美元，12 個月高點為 106.33 美元。該公司的 50 日簡單移動平均線為 84.76 美元，200 日簡單移動平均線為 93.64 美元。該公司的流動比率為 2.54，速動比率為 1.87，債務與股本比率為 0.57。</p>
<ul>
<li>Intuitive Surgical 的拋售為 30% 的反彈機會鋪平道路</li>
</ul>
<p>Medtronic（紐約證券交易所代碼：MDT - 獲取免費報告）最近於 2 月 17 日星期二發佈了季度財報。這家醫療技術公司報告本季度每股收益為 1.36 美元，超出市場共識預期的 1.34 美元 0.02 美元。Medtronic 的股本回報率為 14.82%，淨利潤率為 13.00%。該公司本季度的收入為 90.2 億美元，而分析師預期為 88.9 億美元。在去年同期，該公司每股收益為 1.38 美元。與去年同期相比，該公司的季度收入增長了 5.8%。Medtronic 將其 2026 財年的指引設定為每股收益 5.620-5.660。整體來看，股票分析師預計 Medtronic PLC 今年將發佈每股收益 5.57。</p>
<h2>Medtronic 宣佈分紅</h2>
<p>該公司還最近披露了季度分紅，已於 4 月 17 日星期五支付。3 月 27 日的股東獲得了 0.71 美元的分紅。除息日期為 3 月 27 日。這代表着每年 2.84 美元的分紅，收益率為 3.7%。Medtronic 的分紅支付比率目前為 79.11%。</p>
<h2>分析師升級和降級</h2>
<ul>
<li>5 只可能在 2026 年回報耐心投資者的分拆股票</li>
</ul>
<p>幾位分析師最近對該股票發佈了報告。摩根大通將 Medtronic 的目標價從 105.00 美元下調至 100.00 美元，並在 2 月 18 日的報告中對該股票給予了 “中性” 評級。Weiss Ratings 將 Medtronic 的評級從 “買入（b-）” 下調至 “持有（c+）”，在 4 月 21 日的研究報告中。Jefferies Financial Group 重申了 “持有” 評級，並在 4 月 23 日的研究報告中將 Medtronic 的目標價設定為 95.00 美元。Needham &amp; Company LLC 重申了 “買入” 評級，並在 3 月 26 日的研究報告中將 Medtronic 的目標價設定為 120.00 美元。最後，中金公司在 1 月 30 日的研究報告中對 Medtronic 開展了覆蓋，給予了該股票 “跑贏大盤” 的評級。十五位投資分析師對該股票給予了買入評級，十一位給予了持有評級。根據 MarketBeat，該股票的平均評級為 “適度買入”，平均目標價為 107.80 美元。</p>
<p><strong>查看我們對 MDT 的最新分析</strong></p>
<h2>Medtronic 的內部交易</h2>
<p>在其他 Medtronic 的新聞中，執行副總裁 Harry Skip Kiil 於 2 月 19 日星期四出售了 52,524 股該公司的股票。股票以平均價格 97.71 美元出售，總價值為 5,132,120.04 美元。出售後，該執行副總裁持有 32,768 股該公司的股票，價值約為 3,201,761.28 美元。這代表着他們持有的股票減少了 61.58%。該交易已在向證券交易委員會提交的文件中披露，文件可通過 SEC 網站訪問。內部人士持有該公司 0.26% 的股票。</p>
<h2>Medtronic 公司簡介</h2>
<p>（免費報告）</p>
<p>Medtronic plc 是一家全球醫療技術公司，開發和製造廣泛的治療設備和醫療保健解決方案。公司合法總部位於愛爾蘭，主要運營辦公室位於美國，向全球醫院、醫生和醫療系統銷售產品，自 1949 年成立以來，已發展成為服務全球醫療市場的最大醫療設備製造商之一。</p>
<p>美敦力的產品涵蓋多個臨牀領域，包括心臟節律和心力衰竭（心臟起搏器、植入式心臟復律除顫器及相關心臟治療）、微創和外科技術（腹腔鏡和先進能量設備、可視化系統及外科創新）、修復治療（脊柱和骨科、神經調節和神經血管治療）以及糖尿病管理（胰島素輸送系統和血糖監測解決方案）。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們認為比美敦力更好的股票</li>
<li>維京航運創下歷史新高——基本面信號顯示未來還有更多</li>
<li>Datavalut 獲得關注：現在賣出的五個理由</li>
<li>TMC 股票：為什麼這家無收入礦業公司值得關注</li>
<li>電網正在衰退——是時候購買其替代品了嗎？</li>
</ul>
<p><strong>想看看其他對美敦力持有股份的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取美敦力 PLC（NYSE:MDT - 免費報告）的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在美敦力嗎？</h2>
<p>在考慮美敦力之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而美敦力並不在名單上。</p>
<p>雖然美敦力目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

美敦力

美國醫藥設備 ETF - iShares

醫藥突破 ETF - ALPS

<p>Arbejdsmarkedets Tillaegspension 在美敦力（Medtronic PLC）中獲得了新的股份，購買了 233,477 股，價值約 2240 萬美元。其他投資者也增加了在美敦力的持倉。該公司報告的季度每股收益為 1.36 美元，超出預期，收入為 90.2 億美元。美敦力宣佈季度股息為 0.71 美元，收益率為 3.7%。分析師對該股票的評級不一，平均目標價為 107.80 美元</p>

<p>Arbejdsmarkedets Tillaegspension bought a new stake in shares of Medtronic PLC (NYSE:MDT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 233,477 shares of the medical technology company's stock, valued at approximately $22,428,000.</p>
<div class="lb-trans"><p>Arbejdsmarkedets Tillaegspension 在最近向證券交易委員會的披露中表示，在第四季度購買了 Medtronic PLC（紐約證券交易所代碼：MDT - 免費報告）的新股份。該基金購買了 233,477 股這家醫療技術公司的股票，價值約為 22,428,000 美元。</p>
</div><ul>
<li>3 Reasons Analysts Love DexCom</li>
</ul>
<div class="lb-trans"><ul>
<li>分析師喜愛 DexCom 的 3 個理由</li>
</ul>
</div><p>A number of other large investors also recently bought and sold shares of the business. Brighton Jones LLC boosted its position in shares of Medtronic by 1,368.0% in the fourth quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company's stock worth $3,194,000 after purchasing an additional 37,265 shares during the period. Sivia Capital Partners LLC raised its position in shares of Medtronic by 9.6% in the 2nd quarter. Sivia Capital Partners LLC now owns 4,356 shares of the medical technology company's stock valued at $380,000 after purchasing an additional 381 shares during the last quarter. Jump Financial LLC purchased a new position in Medtronic during the 2nd quarter worth approximately $299,000. Main Street Financial Solutions LLC increased its holdings in shares of Medtronic by 28.9% during the 2nd quarter. Main Street Financial Solutions LLC now owns 14,356 shares of the medical technology company's stock valued at $1,251,000 after purchasing an additional 3,218 shares in the last quarter. Finally, HUB Investment Partners LLC grew its stake in Medtronic by 21.3% in the 2nd quarter. HUB Investment Partners LLC now owns 19,226 shares of the medical technology company's stock valued at $1,676,000 after acquiring an additional 3,376 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他一些大型投資者最近也買賣了該公司的股票。Brighton Jones LLC 在第四季度將其在 Medtronic 的持股比例提高了 1,368.0%。Brighton Jones LLC 現在擁有 39,989 股這家醫療技術公司的股票，價值 3,194,000 美元，此前在該期間內又購買了 37,265 股。Sivia Capital Partners LLC 在第二季度將其在 Medtronic 的持股比例提高了 9.6%。Sivia Capital Partners LLC 現在擁有 4,356 股這家醫療技術公司的股票，價值 380,000 美元，此前在上個季度又購買了 381 股。Jump Financial LLC 在第二季度購買了 Medtronic 的新股份，價值約為 299,000 美元。Main Street Financial Solutions LLC 在第二季度將其在 Medtronic 的持股比例提高了 28.9%。Main Street Financial Solutions LLC 現在擁有 14,356 股這家醫療技術公司的股票，價值 1,251,000 美元，此前在上個季度又購買了 3,218 股。最後，HUB Investment Partners LLC 在第二季度將其在 Medtronic 的持股比例提高了 21.3%。HUB Investment Partners LLC 現在擁有 19,226 股這家醫療技術公司的股票，價值 1,676,000 美元，此前在該期間內又購買了 3,376 股。82.06% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Medtronic Price Performance</h2>
<div class="lb-trans"><h2>Medtronic 股價表現</h2>
</div><p>MDT stock opened at $76.12 on Friday. The company has a market capitalization of $97.73 billion, a P/E ratio of 21.20, a PEG ratio of 1.83 and a beta of 0.62. Medtronic PLC has a twelve month low of $74.40 and a twelve month high of $106.33. The business has a 50 day simple moving average of $84.76 and a 200-day simple moving average of $93.64. The company has a current ratio of 2.54, a quick ratio of 1.87 and a debt-to-equity ratio of 0.57.</p>
<div class="lb-trans"><p>MDT 股票在週五開盤價為 76.12 美元。該公司的市值為 977.3 億美元，市盈率為 21.20，市盈增長比率為 1.83，貝塔值為 0.62。Medtronic PLC 的 12 個月低點為 74.40 美元，12 個月高點為 106.33 美元。該公司的 50 日簡單移動平均線為 84.76 美元，200 日簡單移動平均線為 93.64 美元。該公司的流動比率為 2.54，速動比率為 1.87，債務與股本比率為 0.57。</p>
</div><ul>
<li>Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>Intuitive Surgical 的拋售為 30% 的反彈機會鋪平道路</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last released its quarterly earnings results on Tuesday, February 17th. The medical technology company reported $1.36 EPS for the quarter, topping the consensus estimate of $1.34 by $0.02. Medtronic had a return on equity of 14.82% and a net margin of 13.00%.The business had revenue of $9.02 billion during the quarter, compared to analysts' expectations of $8.89 billion. During the same quarter in the prior year, the business earned $1.38 earnings per share. The company's quarterly revenue was up 5.8% compared to the same quarter last year. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. As a group, equities analysts anticipate that Medtronic PLC will post 5.57 EPS for the current year.</p>
<div class="lb-trans"><p>Medtronic（紐約證券交易所代碼：MDT - 獲取免費報告）最近於 2 月 17 日星期二發佈了季度財報。這家醫療技術公司報告本季度每股收益為 1.36 美元，超出市場共識預期的 1.34 美元 0.02 美元。Medtronic 的股本回報率為 14.82%，淨利潤率為 13.00%。該公司本季度的收入為 90.2 億美元，而分析師預期為 88.9 億美元。在去年同期，該公司每股收益為 1.38 美元。與去年同期相比，該公司的季度收入增長了 5.8%。Medtronic 將其 2026 財年的指引設定為每股收益 5.620-5.660。整體來看，股票分析師預計 Medtronic PLC 今年將發佈每股收益 5.57。</p>
</div><h2>Medtronic Announces Dividend</h2>
<div class="lb-trans"><h2>Medtronic 宣佈分紅</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 17th. Shareholders of record on Friday, March 27th were given a $0.71 dividend. The ex-dividend date was Friday, March 27th. This represents a $2.84 annualized dividend and a yield of 3.7%. Medtronic's dividend payout ratio is presently 79.11%.</p>
<div class="lb-trans"><p>該公司還最近披露了季度分紅，已於 4 月 17 日星期五支付。3 月 27 日的股東獲得了 0.71 美元的分紅。除息日期為 3 月 27 日。這代表着每年 2.84 美元的分紅，收益率為 3.7%。Medtronic 的分紅支付比率目前為 79.11%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師升級和降級</h2>
</div><ul>
<li>5 Spin-Off Stocks That Could Reward Patient Investors in 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只可能在 2026 年回報耐心投資者的分拆股票</li>
</ul>
</div><p>Several analysts recently issued reports on the stock. JPMorgan Chase &amp; Co. reduced their price objective on shares of Medtronic from $105.00 to $100.00 and set a &#34;neutral&#34; rating on the stock in a report on Wednesday, February 18th. Weiss Ratings lowered shares of Medtronic from a &#34;buy (b-)&#34; rating to a &#34;hold (c+)&#34; rating in a research note on Tuesday, April 21st. Jefferies Financial Group reiterated a &#34;hold&#34; rating and set a $95.00 price target on shares of Medtronic in a research note on Thursday, April 23rd. Needham &amp; Company LLC reiterated a &#34;buy&#34; rating and set a $120.00 price target on shares of Medtronic in a research note on Thursday, March 26th. Finally, CICC Research initiated coverage on shares of Medtronic in a research note on Friday, January 30th. They set an &#34;outperform&#34; rating on the stock. Fifteen investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of &#34;Moderate Buy&#34; and an average price target of $107.80.</p>
<div class="lb-trans"><p>幾位分析師最近對該股票發佈了報告。摩根大通將 Medtronic 的目標價從 105.00 美元下調至 100.00 美元，並在 2 月 18 日的報告中對該股票給予了 “中性” 評級。Weiss Ratings 將 Medtronic 的評級從 “買入（b-）” 下調至 “持有（c+）”，在 4 月 21 日的研究報告中。Jefferies Financial Group 重申了 “持有” 評級，並在 4 月 23 日的研究報告中將 Medtronic 的目標價設定為 95.00 美元。Needham &amp; Company LLC 重申了 “買入” 評級，並在 3 月 26 日的研究報告中將 Medtronic 的目標價設定為 120.00 美元。最後，中金公司在 1 月 30 日的研究報告中對 Medtronic 開展了覆蓋，給予了該股票 “跑贏大盤” 的評級。十五位投資分析師對該股票給予了買入評級，十一位給予了持有評級。根據 MarketBeat，該股票的平均評級為 “適度買入”，平均目標價為 107.80 美元。</p>
</div><p><strong>View Our Latest Analysis on MDT</strong></p>
<div class="lb-trans"><p><strong>查看我們對 MDT 的最新分析</strong></p>
</div><h2>Insider Transactions at Medtronic</h2>
<div class="lb-trans"><h2>Medtronic 的內部交易</h2>
</div><p>In other Medtronic news, EVP Harry Skip Kiil sold 52,524 shares of the company's stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $97.71, for a total value of $5,132,120.04. Following the sale, the executive vice president owned 32,768 shares of the company's stock, valued at approximately $3,201,761.28. This represents a 61.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through the SEC website. Insiders own 0.26% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Medtronic 的新聞中，執行副總裁 Harry Skip Kiil 於 2 月 19 日星期四出售了 52,524 股該公司的股票。股票以平均價格 97.71 美元出售，總價值為 5,132,120.04 美元。出售後，該執行副總裁持有 32,768 股該公司的股票，價值約為 3,201,761.28 美元。這代表着他們持有的股票減少了 61.58%。該交易已在向證券交易委員會提交的文件中披露，文件可通過 SEC 網站訪問。內部人士持有該公司 0.26% 的股票。</p>
</div><h2>Medtronic Company Profile</h2>
<div class="lb-trans"><h2>Medtronic 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.</p>
<div class="lb-trans"><p>Medtronic plc 是一家全球醫療技術公司，開發和製造廣泛的治療設備和醫療保健解決方案。公司合法總部位於愛爾蘭，主要運營辦公室位於美國，向全球醫院、醫生和醫療系統銷售產品，自 1949 年成立以來，已發展成為服務全球醫療市場的最大醫療設備製造商之一。</p>
</div><p>Medtronic's offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).</p>
<div class="lb-trans"><p>美敦力的產品涵蓋多個臨牀領域，包括心臟節律和心力衰竭（心臟起搏器、植入式心臟復律除顫器及相關心臟治療）、微創和外科技術（腹腔鏡和先進能量設備、可視化系統及外科創新）、修復治療（脊柱和骨科、神經調節和神經血管治療）以及糖尿病管理（胰島素輸送系統和血糖監測解決方案）。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>Viking Sails to All-Time Highs—Fundamentals Signal More to Come</li>
<li>Datavalut Gains Traction: 5 Reasons to Sell Now</li>
<li>TMC Stock: Why This Pre-Revenue Miner Is Worth Watching</li>
<li>The Power Grid Is Dying—Is It Time to Buy Its Replacement?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比美敦力更好的股票</li>
<li>維京航運創下歷史新高——基本面信號顯示未來還有更多</li>
<li>Datavalut 獲得關注：現在賣出的五個理由</li>
<li>TMC 股票：為什麼這家無收入礦業公司值得關注</li>
<li>電網正在衰退——是時候購買其替代品了嗎？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對美敦力持有股份的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取美敦力 PLC（NYSE:MDT - 免費報告）的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在美敦力嗎？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮美敦力之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而美敦力並不在名單上。</p>
</div><p>While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然美敦力目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Arbejdsmarkedets Tillaegspension Makes New Investment in Medtronic PLC $MDT

Market Beat

紐交所高增長板生物技術指數 ETF - First Trust

2 倍做多納斯達克生物技術 ETF - ProShares

納斯達克生物科技指數 ETF - iShares Nasdaq

生物科技 ETF - VanEck Vectors

動態生物技術與基因組 ETF - Invesco

標普生物技術 ETF - SPDR

標普生物技術 3 倍做多 - Direxion

標普健康醫療設備 ETF - SPDR

直覺外科

摩根大通

Jefferies Financial

中金公司

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Arbejdsmarkedets Tillaegspension 對美敦力 PLC $MDT 進行了新的投資